Costs and consequences: A review of discharge opioid prescribing for ongoing management of acute pain

Anaesthesia and Intensive Care

Volumn 42, Issue 5, 2014, Pages 558-574

  Macintyre, P E ^a   Huxtable, C A ^a   Flint, S L P ^b   Dobbin, M D H ^c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Anxiety; Depression; Inappropriate prescribing; Opioid misuse; Opioid related adverse effects; Opioids; Postoperative pain

Indexed keywords

NARCOTIC ANALGESIC AGENT;

ANXIETY; DEPRESSION; DRUG INTERACTION; DRUG SELF ADMINISTRATION; HEALTH CARE COST; HOSPITAL DISCHARGE; HUMAN; INAPPROPRIATE PRESCRIBING; INTERPERSONAL COMMUNICATION; OPIATE ADDICTION; OPIOID MISUSE; OPIOID-RELATED ADVERSE EFFECTS; OPIOIDS; PAIN; POSTOPERATIVE PAIN; REVIEW;

ANXIETY; DEPRESSION; INAPPROPRIATE PRESCRIBING; OPIOID MISUSE; OPIOID-RELATED ADVERSE EFFECTS; OPIOIDS; POSTOPERATIVE PAIN;

ACUTE PAIN; ANALGESICS, OPIOID; COMMUNICATION; DRUG INTERACTIONS; HEALTH CARE COSTS; HUMANS; INAPPROPRIATE PRESCRIBING; OPIOID-RELATED DISORDERS; PATIENT DISCHARGE; SELF ADMINISTRATION;

EID: 84907930970     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1404200504     Document Type: Review

References (149)

1. Forster AJ, Clark HD, Menard A, Dupuis N, Chernish R, Chandok N et al. Adverse events among medical patients after discharge from hospital. CMAJ 2004; 170:345-349.
2. Spehar AM, Campbell RR, Cherrie C, Palacios P, Scott D, Baker JL et al. Advances in Patient Safety: From Research to Implementation. Volumes 1-4. February 2005. From http://www.ahrq.gov/professionals/quality-patient-safety/ patient-safety-resources/resources/advances-in-patientsafety/ index.html. Accessed December 2013.
3. Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital inpatients: a prospective analysis of 3695 patient-episodes. PLoS One 2009; 4:e4439. ?
4. Australian Institute of Health and Welfare. Surgery in Australian Hospitals 2010-2011. From https://www.aihw. gov.au/WorkArea/DownloadAsset.aspx?id=10737422256. Accessed January 2014.
5. Centers for Disease Control and Prevention. Faststats: Inpatient Surgery 2010. From http://www.cdc.gov/nchs/fastats/ insurg.htm. Accessed January 2014.
6. Scott NB, McDonald D, Campbell J, Smith RD, Carey AK, Johnston IG et al. The use of enhanced recovery after surgery (ERAS) principles in Scottish orthopaedic units-an implementation and follow-up at 1 year, 2010-2011: a report from the Musculoskeletal Audit, Scotland. Arch Orthop Trauma Surg 2013; 133:117-124.
7. Lv L, Shao YF, Zhou YB. The enhanced recovery after surgery (ERAS) pathway for patients undergoing colorectal surgery: an update of meta-analysis of randomized controlled trials. Int J Colorectal Dis 2012; 27:1549-1554. ?
8. Carter J. Fast-track surgery in gynaecology and gynaecologic oncology: a review of a rolling clinical audit. ISRN Surg 2012; 2012:368014.
9. Coolsen MME, Wong-Lun-Hing EM, van Dam RM, van der Wilt AA, Slim K, Lassen K et al. A systematic review of outcomes in patients undergoing liver surgery in an enhanced recovery after surgery pathways. HPB (Oxford) 2013; 15:245-251.
10. Coolsen MME, van Dam RM, van der Wilt AA, Slim K, Lassen K, Dejong CHC. Systematic review and meta-analysis of enhanced recovery after pancreatic surgery with particular emphasis on pancreaticoduodenectomies. World J Surg 2013; 37:1909-1918.
11. Padua L, Aprile I, Cecchi F, Molino Lova R, Arezzo MF, Pazzaglia C. Pain in postsurgical orthopedic rehabilitation: a multicenter study. Pain Med 2012; 13:769-776.
12. Steyaert A, Lavand'homme P. Postoperative opioids: let us take responsibility for the possible consequences. Eur J Anaesthesiol 2013; 30:50-52.
13. Carroll I, Barelka P, Wang CK, Wang BM, Gillespie MJ, McCue R et al. A pilot cohort study of the determinants of longitudinal opioid use after surgery. Anesth Analg 2012; 115:694-702.
14. Alam A, Gomes T, Zheng H, Mamdani MM, Juurlink DN, Bell CM. Long-term analgesic use after low-risk surgery: a retrospective cohort study. Arch Intern Med 2012; 172:425-430.
15. Singh JA, Lewallen DG. Predictors of pain and use of pain medications following primary Total Hip Arthroplasty (THA): 5,707 THAs at 2-years and 3,289 THAs at 5-years. BMC Musculoskelet Disord 2010; 11:90.
16. Singh JA, Lewallen DG. Predictors of use of pain medications for persistent knee pain after primary Total Knee Arthroplasty: a cohort study using an institutional joint registry. Arthritis Res Ther 2012; 14:R248.
17. Singh JA, Lewallen DG. Predictors of pain medication use for arthroplasty pain after revision total knee arthroplasty. Rheumatology (Oxford) 2014
18. Ballantyne JC, Shin NS. Efficacy of opioids for chronic pain: a review of the evidence. Clin J Pain 2008; 24:469-478.
19. Kissin I. Long-term opioid treatment of chronic nonmalignant pain: unproven efficacy and neglected safety. J Pain Res 2013; 6:513-529.
20. Harris K, Curtis J, Larsen B, Calder S, Duffy K, Bowen G et al. Opioid pain medication use after dermatologic surgery: a prospective observational study of 212 dermatologic surgery patients. JAMA Dermatol 2013; 149:317-321.
21. Bates C, Laciak R, Southwick A, Bishoff J. Overprescription of postoperative narcotics: a look at postoperative pain medication delivery, consumption and disposal in urological practice. J Urol 2011; 185:551-555.
22. Rodgers J, Cunningham K, Fitzgerald K, Finnerty E. Opioid consumption following outpatient upper extremity surgery. J Hand Surg Am 2012; 37:645-650.
23. Platis A, Wenzel T. Hospital Oxycodone Utilisation Research Study (HOURS), Royal Adelaide Hospital, North Terrace, South Australia 2011.
24. Steele N, Stevens J. Where oh where has your Endone script gone? The oxycodone epidemic. From http://asp-au.securezone. net/v2/index.jsp?id=522/576/4135&lng=en. Accessed December 2013
25. Kessler ER, Shah M, Gruschkus SK, Raju A. Cost and quality implications of opioid-based postsurgical pain control using administrative claims data from a large health system: opioid-related adverse events and their impact on clinical and economic outcomes. Pharmacotherapy 2013; 33:383-391.
26. Macintyre PE, Loadsman JA, Scott DA. Opioids, ventilation and acute pain management. Anaesth Intensive Care 2011; 39:545-558.
27. Dahan A, Aarts L, Smith TW. Incidence, reversal, and prevention of opioid-induced respiratory depression. Anesthesiology 2010; 112:226-238.
28. Lee LA, Domino KB. Factors associated with postoperative respiratory depression: from the ASA Closed Claims Analysis. From http://viewer.zmags.com/publication/639191e9#/639191e9/1. Accessed August 2013.
29. White JM, Irvine RJ. Mechanisms of fatal opioid overdose. Addiction 1999; 94:961-972.
30. Gomes T, Mamdani MM, Dhalla IA, Paterson JM, Juurlink DN. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med 2011; 171:686-691.
31. Green TC, Grau LE, Carver HW, Kinzly M, Heimer R. Epidemiologic trends and geographic patterns of fatal opioid intoxications in Connecticut, USA: 1997-2007. Drug Alcohol Depend 2011; 115:221-228.
32. Webster LR, Cochella S, Dasgupta N, Fakata KL, Fine PG, Fishman SM et al. An analysis of the root causes for opioidrelated overdose deaths in the United States. Pain Med 2011; 12 Suppl 2:S26-S35.
33. Paulozzi LJ, Kilbourne EM, Shah NG, Nolte KB, Desai HA, Landen MG et al. A history of being prescribed controlled substances and risk of drug overdose death. Pain Med 2012; 13:87-95.
34. Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA 2013; 309:657-659.
35. Rintoul AC, Dobbin MDH, Nielsen S, Degenhardt L, Drummer OH. Recent increase in detection of alprazolam in Victorian heroin-related deaths. Med J Aust 2013; 198:206-209.
36. Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med 2010; 152:85-92.
37. Bohnert ASB, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 2011; 305:1315-1321.
38. Solomon DH, Rassen JA, Glynn RJ, Garneau K, Levin R, Lee J et al. The comparative safety of opioids for nonmalignant pain in older adults. Arch Intern Med 2010; 170:1979-1786.
39. Rolita L, Spegman A, Tang X, Cronstein BN. Greater number of narcotic analgesic prescriptions for osteoarthritis is associated with falls and fractures in elderly adults. J Am Geriatr Soc 2013; 61:335-340.
40. Soderberg KC, Laflamme L, Moller J. Newly initiated opioid treatment and the risk of fall-related injuries. A nationwide, register-based, case-crossover study in Sweden. CNS Drugs 2013; 27:155-161.
41. Baldini A, Von Korff M, Lin EHB. A review of potential adverse effects of long-term opioid therapy: a practitioner's guide. Prim Care Companion CNS Disord 2012; 14:n/a.
42. United Nations Office on Drugs and Crimes. World Drug Report 2013. From http://www.unodc.org/wdr/. Accessed November 2013.
43. Drummer OH, Gerostamoulos J, Batziris H, Chu M, Caplehorn JRM, Robertson MD et al. The incidence of drugs in drivers killed in Australian road traffic crashes. Forensic Sci Int 2003; 134:154-162.
44. Wilhelmi BG, Cohen SP. A framework for "driving under the influence of drugs" policy for the opioid using driver. Pain Physician 2012; 15:ES215-ES230.
45. Drug and Alcohol Services South Australia. Benzodiazepines, opioids and driving: information for the prescriber. From http://www.sahealth.sa.gov.au/wps/wcm/connect/b0da1e-0041794199a6eeef67a94f09f9/Benzo+and+Driving+-+Info+forPrescribers-DASSA-Oct2013.pdf?MOD=AJP ERES&CACHEID=b0da1e0041794199a6eeef67a94f09f9. Accessed August 2013.
46. Australian Drug Foundation. Drugs and Driving. From http:// www.druginfo.adf.org.au/attachments/338-ADFPRQ0310- www.pdf. Accessed November 2013.
47. Dassanayake T, Michie P, Carter G, Jones A. Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence. Drug Saf 2011; 34:125-156.
48. Austroads. Assessing fitness to drive for commercial and private vehicle drivers. From http://www.austroads.com.au/images/stories/ AFTD-reduced-for-web.pdf. Accessed November 2013
49. 49. Mailis-Gagnon A, Lakha SF, Furlan A, Nicholson K, Yegneswaran B, Sabatowski R. Systematic review of the quality and generalizability of studies on the effects of opioids on driving and cognitive/psychomotor performance. Clin J Pain 2012; 28:542-555.
50. Gomes T, Redelmeier DA, Juurlink DN, Dhalla IA, Camacho X, Mamdani MM. Opioid dose and risk of road trauma in Canada: a population-based study. JAMA Intern Med 2013; 173:196-201.
51. European Monitoring Centre for Drugs and Addiction. Driving Under the Influence of Drugs, Alcohol and Medicines in Europe - findings from the DRUID project. From http:// www.emcdda.europa.eu/publications/thematic-papers/druid. Accessed December 2013.
52. Ramaekers J. Driving under the Influence of Drugs, Alcohol and Medicines (DRUID): Effects of medicinal drugs on actual and simulated driving. From http://www.druid-project.eu/ cln-031/nn-107548/Druid/EN/deliverales-list/downloads/Deli verable-1-2-2,templateId=raw,property=publicationFile. pdf/Deliverable-1-2-2.pdf. Accessed December 2013.
53. Pergolizzi JV. Quantifying the impact of drug-drug interactions associated with opioids. Am J Manag Care 2011; 17 Suppl 11:S288-S292.
54. Rintoul AC, Dobbin MDH, Drummer OH, Ozanne-Smith J. Increasing deaths involving oxycodone, Victoria, Australia, 2000-09. Inj Prev 2011; 17:254-259.
55. Roxburgh A, Bruno R, Larance B, Burns L. Prescription of opioid analgesics and related harms in Australia. Med J Aust 2011; 195:280-284.
56. Pergolizzi JV Jr, Labhsetwar SA, Puenpatom RA, Joo S, Ben-Joseph RH, Summers KH. Prevalence of exposure to potential CYP450 pharmacokinetic drug-drug interactions among patients with chronic low back pain taking opioids. Pain Pract 2011; 11:230-239.
57. Pergolizzi JV Jr, Labhsetwar SA, Puenpatom RA, Joo S, Ben-Joseph R, Summers KH. Exposure to potential CYP450 pharmacokinetic drug-drug interactions among osteoarthritis patients: incremental risk of multiple prescriptions. Pain Pract 2011; 11:325-336.
58. Ellis J, Mullan J. Prescription medication borrowing and shar-ing-risk factors and management. Aust Fam Physician 2009; 38:816-819.
59. Ward L, Patel NM, Hanlon A, Eldakar-Hein S, Sherlinski K, Ward SH. Prescription medication borrowing among adult patients at an urban medical center. J Urban Health 2011; 88:997-1014.
60. Von Korff MR. Long-term use of opioids for complex chronic pain. Best Pract Res Clin Rheumatol 2013; 27:663-672.
61. Burghardt LC, Ayers JW, Brownstein JS, Bronstein AC, Ewald MB, Bourgeois FT. Adult prescription drug use and pediatric medication exposures and poisonings. Pediatrics 2013; 132:18-27.
62. Substance Abuse and Mental Health Services Administration. Results from the 2011 National Survey on Drug Use and Health: Summary of National Findings. From http://www. samhsa.gov/data/NSDUH/2k11Results/NSDUHresults2011.pdf. Accessed April 2013.
63. Raffa RB, Pergolizzi JV Jr, Muniz E, Taylor R Jr, Pergolizzi J. Designing opioids that deter abuse. Pain Res Treat 2012; 2012:282981.
64. Stafford J, Burns L. Australian Drug Trends 2012: Findings from the Illicit Drug Reporting System (IDRS). From http:// ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/ National%20IDRS%20report%202012.pdf. Accessed August 2013.
65. Inciardi JA, Surratt HL, Cicero TJ, Beard RA. Prescription opioid abuse and diversion in an urban community: the results of an ultrarapid assessment. Pain Med 2009; 10:537-548.
66. Oxford University Press. Word of the Month: Fossil Farming. From http://andc.anu.edu.au/sites/default/files/WOTM%20 fossil%20farming%20Dec%202012.pdf. Accessed May 2013.
67. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. Monitoring the future: National Survey Results on Drug Use 1975-2012. 2012 Overview: Key Findings on Adolescent Drug Use. From http://www.monitoringthefuture.org/pubs/monographs/ mtf-overview2012.pdf. Accessed November 2013.
68. Manchikanti L, Helm S 2nd, Fellows B, Janata JW, Pampati V, Grider JS et al. Opioid epidemic in the United States. Pain Physician 2012; 15:ES9-ES38.
69. Stafford J, Degenhardt L, Black E, Bruno R, Buckingham K, Fetherston J et al. Australian Drug Trends 2005: Findings from the Illicit Drug Reporting System (IDRS). From http://ndarc. med.unsw.edu.au/NDARCWeb.nsf/resources/Mono-1/$file/ Mono.59.pdf. Accessed March 2011.
70. Centers for Disease Control and Prevention. QuickStats: Number of Deaths From Poisoning, Drug Poisoning, and Drug Poisoning Involving Opioid Analgesics - United States, 1999-2010. From http://www.cdc.gov/mmwr/preview/mmwrhtml/ mm6212a7.htm?s-cid=mm6212a7-w. Accessed August 2013.
71. Centers for Disease Control and Prevention. Vital Signs: Overdoses of Prescription Opioid Pain Relievers and Other Drugs Among Women - United States, 1999-2010. From http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6226a3.htm. Accessed November 2013.
72. Substance Abuse and Mental Health Services Administration. Highlights of the 2011 Drug Abuse Warning Network (DAWN) Findings on Drug-Related Emergency Department Visits. From http://www.samhsa.gov/data/2k13/DAWN127/sr127-DAWN-highlights.pdf. Accessed April 2013.
73. Leong M, Murnion B, Haber PS. Examination of opioid prescribing in Australia from 1992 to 2007. Intern Med J 2009; 39:676-681.
74. Bailey JE, Campagna E, Dart RC. The underrecognized toll of prescription opioid abuse on young children. Ann Emerg Med 2009; 53:419-424.
75. Martin BC, Fan MY, Edlund MJ, Devries A, Braden JB, Sullivan MD. Long-term chronic opioid therapy discontinuation rates from the TROUP study. J Gen Intern Med 2011; 26:1450-1457.
76. Sullivan MD, Ballantyne JC. What are we treating with longterm opioid therapy? Arch Intern Med 2012; 172:433-434.
77. Caumo W, Schmidt AP, Schneider CN, Bergmann J, Iwamoto CW, Adamatti LC et al. Preoperative predictors of moderate to intense acute postoperative pain in patients undergoing abdominal surgery. Acta Anaesthesiol Scand 2002; 46:1265-1271.
78. Ozalp G, Sarioglu R, Tuncel G, Aslan K, Kadiogullari N. Preoperative emotional states in patients with breast cancer and postoperative pain. Acta Anaesthesiol Scand 2003; 47:26-29.
79. Katz J, Poleshuck EL, Andrus CH, Hogan LA, Jung BF, Kulick DI et al. Risk factors for acute pain and its persistence following breast cancer surgery. Pain 2005; 119:16-25.
80. Roth ML, Tripp DA, Harrison MH, Sullivan M, Carson P. Demographic and psychosocial predictors of acute perioperative pain for total knee arthroplasty. Pain Res Manag 2007; 12:185-194.
81. De CG, Congedo E, Lai C, Primieri P, Dottarelli A, Aceto P. Preoperative psychologic and demographic predictors of pain perception and tramadol consumption using intravenous patient-controlled analgesia. Clin J Pain 2008; 24:399-405.
82. Rakel BA, Blodgett NP, Bridget ZM, Logsden-Sackett N, Clark C, Noiseux N et al. Predictors of postoperative movement and resting pain following total knee replacement. Pain 2012; 153:2192-2203.
83. Goebel S, Steinert A, Vierheilig C, Faller H. Correlation between depressive symptoms and perioperative pain: a prospective cohort study of patients undergoing orthopedic surgeries. Clin J Pain 2013; 29:392-399.
84. Pinto PR, McIntyre T, Ferrero R, Almeida A, Araujo-Soares V. Predictors of acute postsurgical pain and anxiety following primary total hip and knee arthroplasty. J Pain 2013; 14:502-515.
85. Quartana PJ, Campbell CM, Edwards RR. Pain catastrophizing: a critical review. Expert Rev Neurother 2009; 9:745-758.
86. Theunissen M, Peters ML, Bruce J, Gramke HF, Marcus MA. Preoperative anxiety and catastrophizing: a systematic review and meta-analysis of the association with chronic postsurgical pain. Clin J Pain 2012; 28:819-841.
87. Hinrichs-Rocker A, Schulz K, Jarvinen I, Lefering R, Simanski C, Neugebauer EAM. Psychosocial predictors and correlates for chronic post-surgical pain (CPSP): a systematic review. Eur J Pain 2009; 13:719-730.
88. Wylde V, Hewlett S, Learmonth ID, Dieppe P. Persistent pain after joint replacement: prevalence, sensory qualities, and postoperative determinants. Pain 2011; 152:566-572.
89. Pinto PR, McIntyre T, Nogueira-Silva C, Almeida A, Araujo-Soares V. Risk factors for persistent postsurgical pain in women undergoing hysterectomy due to benign causes: a prospective predictive study. J Pain 2012; 13:1045-1057.
90. Belfer I, Schreiber KL, Shaffer JR, Shnol H, Blaney K, Morando A et al. Persistent postmastectomy pain in breast cancer survivors: analysis of clinical, demographic, and psychosocial factors. J Pain 2013; 14:1185-1195.
91. Pinto PR, McIntyre T, Ferrero R, Almeida A, Araujo-Soares V. Risk factors for moderate and severe persistent pain in patients undergoing total knee and hip arthroplasty: a prospective predictive study. PLoS One 2013; 8:e73917.
92. Schreiber KL, Martel MO, Shnol H, Shaffer JR, Greco C, Viray N et al. Persistent pain in postmastectomy patients: comparison of psychophysical, medical, surgical, and psychosocial characteristics between patients with and without pain. Pain 2013; 154:660-668.
93. Bortsov AV, Platts-Mills TF, Peak DA, Jones JS, Swor RA, Domeier RM et al. Pain distribution and predictors of widespread pain in the immediate aftermath of motor vehicle collision. Eur J Pain 2013; 17:1243-1251.
94. Clay FJ, Newstead SV, Watson WL, Ozanne-Smith J, Guy J, McClure RJ. Bio-psychosocial determinants of persistent pain 6 months after non-life-threatening acute orthopaedic trauma. J Pain 2010; 11:420-430.
95. Castillo RC, Wegener ST, Heins SE, Haythornthwaite JA, Mackenzie EJ, Bosse MJ. Longitudinal relationships between anxiety, depression, and pain: results from a two-year cohort study of lower extremity trauma patients. Pain 2013; 154:2860-2866.
96. Rosenbloom BN, Khan S, McCartney C, Katz J. Systematic review of persistent pain and psychological outcomes following traumatic musculoskeletal injury. J Pain Res 2013; 6:39-51.
97. Breckenridge J, Clark JD. Patient characteristics associated with opioid versus nonsteroidal anti-inflammatory drug management of chronic low back pain. J Pain 2003; 4:344-350.
98. Sullivan MD, Edlund MJ, Zhang L, Unutzer J, Wells KB. Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med 2006; 166:2087-2093.
99. Young Casey C, Greenberg MA, Nicassio PM, Harpin RE, Hubbard D. Transition from acute to chronic pain and disability: a model including cognitive, affective, and trauma factors. Pain 2008; 134:69-79.
100. Franklin GM, Rahman EA, Turner JA, Daniell WE, Fulton-Kehoe D. Opioid use for chronic low back pain: a prospective, population-based study among injured workers in Washington state, 2002-2005. Clin J Pain 2009; 25:743-751.
101. Edlund MJ, Martin BC, Devries A, Fan MY, Braden JB, Sullivan MD. Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: the TROUP study. Clin J Pain 2010; 26:1-8.
102. Richardson LP, Russo JE, Katon W, McCarty CA, DeVries A, Edlund MJ et al. Mental health disorders and long-term opioid use among adolescents and young adults with chronic pain. J Adolesc Health 2012; 50:553-558.
103. Sullivan MD, Howe CQ. Opioid therapy for chronic pain in the United States: promises and perils. Pain 2013; 154 Suppl 1:S94-S100.
104. Fischer B, Lusted A, Roerecke M, Taylor B, Rehm J. The prevalence of mental health and pain symptoms in general population samples reporting nonmedical use of prescription opioids: a systematic review and meta-analysis. J Pain 2012; 13:1029-1044.
105. Koyyalagunta D, Bruera E, Aigner C, Nusrat H, Driver L, Novy D. Risk stratification of opioid misuse among patients with cancer pain using the SOAPP-SF. Pain Med 2013; 14:667-675.
106. Morasco BJ, Turk DC, Donovan DM, Dobscha SK. Risk for prescription opioid misuse among patients with a history of substance use disorder. Drug Alcohol Depend 2013; 127:193-199.
107. Sansone RA, Watts DA, Wiederman MW. The misuse of prescription pain medication and borderline personality symptomatology. J Opioid Manag 2013; 9:275-279.
108. Rice JB, White AG, Birnbaum HG, Schiller M, Brown DA, Roland CL. A model to identify patients at risk for prescription opioid abuse, dependence, and misuse. Pain Med 2012; 13:1162-1173.
109. Bruera E, Moyano J, Seifert L, Fainsinger RL, Hanson J, Suarez-Almazor M. The frequency of alcoholism among patients with pain due to terminal cancer. J Pain Symptom Manage 1995; 10:599-603.
110. Kirsh KL, Jass C, Bennett DS, Hagen JE, Passik SD. Initial development of a survey tool to detect issues of chemical coping in chronic pain patients. Palliat Support Care 2007; 5:219-226.
111. Passik SD, Lowery A. Psychological variables potentially implicated in opioid-related mortality as observed in clinical practice. Pain Med 2011; 12 Suppl 2:S36-S42.
112. Skala K, Reichl L, Ilias W, Likar R, Grogl-Aringer G, Wallner C et al. Can we predict addiction to opioid analgesics? A possible tool to estimate the risk of opioid addiction in patients with pain. Pain Physician 2013; 16:593-601.
113. Miotto K, Kaufman A, Kong A, Jun G, Schwartz J. Managing co-occurring substance use and pain disorders. Psychiatr Clin North Am 2012; 35:393-409.
114. Jovey R. Opioids, pain and addiction - practical strategies. British Journal of Pain 2012; 6:36-42.
115. Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. A single-question screening test for drug use in primary care. Arch Intern Med 2010; 170:1155-1160.
116. Passik SD, Kirsh KL, Casper D. Addiction-related assessment tools and pain management: instruments for screening, treatment planning, and monitoring compliance. Pain Medicine 2008; 9:S145-S166.
117. Chou R, Fanciullo GJ, Fine PG, Miaskowski C, Passik SD, Portenoy RK. Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 2009; 10:131-146.
118. Becker WC, Fraenkel L, Edelman EJ, Holt SR, Glover J, Kerns RD et al. Instruments to assess patient-reported safety, efficacy, or misuse of current opioid therapy for chronic pain: a systematic review. Pain 2013; 154:905-916.
119. Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med 2005; 6:432-442.
120. Jones T, Passik SD. A comparison of methods of administering the opioid risk tool. J Opioid Manag 2011; 7:347-351.
121. Moore TM, Jones T, Browder JH, Daffron S, Passik SD. A comparison of common screening methods for predicting aberrant drug-related behavior among patients receiving opioids for chronic pain management. Pain Med 2009; 10:1426-1433.
122. Jones T, Moore T. Preliminary data on a new opioid risk assessment measure: the Brief Risk Interview. J Opioid Manag 2013; 9:19-27.
123. Passik SD. Issues in long-term opioid therapy: unmet needs, risks, and solutions. Mayo Clin Proc 2009; 84:593-601.
124. Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med 2005; 6:107-112.
125. Webster LR, Fine PG. Approaches to improve pain relief while minimizing opioid abuse liability. J Pain 2010; 11:602-611.
126. Von Korff M, Merrill JO, Rutter CM, Sullivan M, Campbell CI, Weisner C. Time-scheduled vs. pain-contingent opioid dosing in chronic opioid therapy. Pain 2011; 152:1256-1262.
127. Food and Drug Administration. FDA Drug Safety Communication: Codeine use in certain children after tonsillectomy and/or adenoidectomy may lead to rare, but lifethreatening adverse events or death. From http://www.fda.gov/ drugs/drugsafety/ucm313631.htm. Accessed December 2013.
128. Kirchheiner J, Keulen JTHA, Bauer S, Roots I, Brockmoller J. Effects of the CYP2D6 gene duplication on the pharmacokinetics and pharmacodynamics of tramadol. J Clin Psychopharmacol 2008; 28:78-83.
129. Butler SF, Fernandez KC, Chang A, Benoit C, Morey LC, Black R et al. Measuring attractiveness for abuse of prescription opioids. Pain Med 2010; 11:67-80.
130. Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. Factors influencing the selection of hydrocodone and oxycodone as primary opioids in substance abusers seeking treatment in the United States. Pain 2013; 154:2639-2648.
131. Frei MY, Nielsen S, Dobbin MDH, Tobin CL. Serious morbidity associated with misuse of over-the-counter codeineibuprofen analgesics: a series of 27 cases. Med J Aust 2010; 193:294-296.
132. Severtson SG, Bartelson BB, Davis JM, Munoz A, Schneider MF, Chilcoat H et al. Reduced abuse, therapeutic errors, and diversion following reformulation of extended-release oxycodone in 2010. J Pain 2013; 14:1122-1130.
133. Cicero TJ, Ellis MS, Surratt HL. Effect of abuse-deterrent formulation of OxyContin. N Engl J Med 2012; 367:187-189.
134. Butler SF, Cassidy TA, Chilcoat H, Black RA, Landau C, Budman SH et al. Abuse rates and routes of administration of reformulated extended-release oxycodone: initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatment. J Pain 2013; 14:351-358.
135. Brown KR, Severtson SG, Dart RC. RADARS System Poison Center Intentional Exposures to OxyContin : A look at the differences in rates of abuse via unintended routes before and after reformulation intervention. North American Congress of Clinical Toxicology (NACCT) Annual Meeting. Las Vegas, United States of America 2012.
136. Moorman-Li R, Motycka CA, Inge LD, Congdon JM, Hobson S, Pokropski B. A review of abuse-deterrent opioids for chronic nonmalignant pain. P T 2012; 37:412-418.
137. McQuay H. Relief of Chronic Non-Malignant Pain. From http://www.medicine.ox.ac.uk/bandolier/booth/painpag/ wisdom/493HJM.html. Accessed May 2011.
138. Royal Adelaide Hospital and SA Health. Information for Patients Given Oxycodone for the Short-term Treatment of Acute Pain. From http://www.sahealth.sa.gov.au/wps/wcm/ connect/cfe6c68049e4dcf0b464fe3a89b74631/12563-SA+Hea lth+Pharm+OxycodoneAcutePain.pdf?MOD=AJPERES& CACHEID=cfe6c68049e4dcf0b464fe3a89b74631. Accessed December 2013.
139. Watt-Watson J, McGillion M, Hunter J, Choiniere M, Clark AJ, Dewar A et al. A survey of prelicensure pain curricula in health science faculties in Canadian universities. Pain Res Manag 2009; 14:439-444.
140. Briggs EV, Carr ECJ, Whittaker MS. Survey of undergraduate pain curricula for healthcare professionals in the United Kingdom. Eur J Pain 2011; 15:789-795.
141. Doorenbos AZ, Gordon DB, Tauben D, Palisoc J, Drangsholt M, Lindhorst T et al. A blueprint of pain curriculum across prelicensure health sciences programs: one NIH Pain Consortium Center of Excellence in Pain Education (CoEPE) experience. J Pain 2013; 14:1533-1538.
142. Morley-Forster PK, Pergolizzi JV, Taylor R Jr, Axford-Gatley RA, Sellers EM. Mitigating the risk of opioid abuse through a balanced undergraduate pain medicine curriculum. J Pain Res 2013; 6:791-801.
143. Fishman SM, Young HM, Lucas AE, Chou R, Herr K, Murinson BB et al. Core competencies for pain management: results of an interprofessional consensus summit. Pain Med 2013; 14:971-981.
144. Murinson BB, Gordin V, Flynn S, Driver LC, Gallagher RM, Grabois M. Recommendations for a new curriculum in pain medicine for medical students: toward a career distinguished by competence and compassion. Pain Med 2013; 14:345-350.
145. Tauben DJ, Loeser JD. Pain education at the University of Washington School of Medicine. J Pain 2013; 14:431-437.
146. Royal Adelaide Hospital and SA Health. Opioids: Guidelines for Prescribing on Discharge. From http://www.sahealth.sa.gov. au/wps/wcm/connect/d0c9770041a43af3b0daf6c8f6e9796e/ Opioids-Guidelines+for+Prescribing+on+Discharge- Oct2013.pdf?MOD=AJPERES&CACHEID=d0c9770041a43 af3b0daf6c8f6e9796e. Accessed December 2013.
147. McCoy D. Fear and loathing in the operating room. In: Riley R ed. Australasian Anaesthesia 2013. Melbourne, Australian and New Zealand College of Anaesthetists 2013.
148. Centers for Disease Control and Prevention. CDC Grand Rounds: Prescription Drug Overdoses - a U.S. Epidemic. From http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6101a3.htm. Accessed February 2014.
149. Canadian Centre on Substance Abuse National Advisory Committee on Prescription Drug Misuse. First Do No Harm: Responding to Canada's Prescription Drug Crisis. From http:// www.ccsa.ca/2013%20CCSA%20Documents/Canada-Strategy-Prescription-Drug-Misuse-Report-en.pdf. Accessed February 2014.